Organon & Co. (OGN) earnings date

NYSE · Mid cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 36 days, typically, give or take 6 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q1 FY2026Thu, Apr 30, 2026before open 30 8-K
Q4 FY2025Thu, Feb 12, 2026before open 43 8-K
Q3 FY2025Mon, Nov 10, 2025before open 41 8-K
Q2 FY2025Tue, Aug 5, 2025before open 36 8-K
Q1 FY2025Thu, May 1, 2025before open 31 8-K
Q4 FY2024Thu, Feb 13, 2025before open 44 8-K
Q3 FY2024Thu, Oct 31, 2024before open 31 8-K
Q2 FY2024Tue, Aug 6, 2024before open 37 8-K

What they guided beta

Q1 FY2026 "To the extent holdings of Organon’s securities by its directors or executive officers have changed since the amounts set forth in the 2026 Annual Meeting Proxy Statement, such changes have been or will be reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC, which are available at https://www.sec.gov/edgar/browse/?CIK=1821825 ." exhibit
Q4 FY2025 "· The company expects to deliver approximately $6.2 billion of revenue and approximately $1.9 billion of Adjusted EBITDA for the full year 2026, both measures in-line with full year 2025 performance." exhibit
Q4 FY2025 "Sales of Nexplanon® (etonogestrel implant) decreased 20% ex-FX in the fourth quarter compared with the prior year period primarily due to: an approximate $17 million decrease in sales due to the cessation of certain identified U.S. wholesaler sales practices described in the company’s Form 8-K filed with the U.S. Securities and Exchange Commission on October 27, 2025; lower U.S. demand mainly associated with policy-related access restrictions and a reduction in physician demand in certain commercial segments; and an increase in the rebate rate in the U.S. attributable to patient mix." exhibit
Q4 FY2025 "The year-over-year decline in the fourth quarter 2025 Adjusted EBITDA margin was primarily driven by the lower Adjusted Gross Margin, which was only partially offset by a 5% reduction in non-GAAP operating expenses." exhibit
Q4 FY2025 "Adjusted EBITDA margin was 30.7% for full year 2025 consistent with full year 2024 as the decline in Adjusted gross margin was substantially offset by lower R&D expense." exhibit
Q4 FY2025 "The company is not aware of the need for any changes to prior financial statements, and currently anticipates that it will be able to timely file its Form 10-K for the year ended December 31, 2025 and update its disclosure in relation to this matter." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/OGN
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/OGN

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

OGN earnings date badge

HTML

<a href="https://veritasdata.dev/company/OGN/"><img src="https://veritasdata.dev/embed/OGN.svg" alt="OGN earnings date" width="240" height="56"></a>

Markdown

[![OGN earnings date](https://veritasdata.dev/embed/OGN.svg)](https://veritasdata.dev/company/OGN/)

Script

<script async src="https://veritasdata.dev/embed/OGN.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/OGN"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.